SCNX:NASDAQScienture Holdings, Inc. Analysis
Data as of 2026-09-05 - not real-time
$0.37
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Scienture Holdings, Inc. trades at $0.3730, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 1.1% over the past 30 days. With RSI at 41.0 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $0.3530 and resistance around $0.4810.
Analyst price targets sit 302.1% above the current price.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 62.2%, a beta of 2.65 and a maximum drawdown of 90.7%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Analyst price targets sit 302.1% above the current price.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 62.2%, a beta of 2.65 and a maximum drawdown of 90.7%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
SCIENTURE has commercially launched REZENOPY, its 10 mg naloxone nasal spray, and fulfilled initial purchase orders to...COMMACK, N.Y. AP — COMMACK, N.Y. AP — Scienture Holdings, Inc. SCNX on Thursday reported a loss of $2.8 million in...SCIENTURE Announces Commercial Launch And Fulfillment Of Initial Purchase Orders Of REZENOPYTM, The Highest Dose...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 0.44
- MACD momentum is negative
- 30-day volatility of 62.2%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 0.44
- Analyst targets imply +302.1% versus the current price
- 30-day volatility of 62.2%
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +302.1% versus the current price
- Negative return on equity of -53.5%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
ROE-53.47%
ROA-8.93%
Debt/Equity16.68
P/B Ratio0.2
Op. Cash Flow$-14440576
Free Cash Flow$-7611433
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI41.0
Support$0.35
Resistance$0.48
MA 20$0.42
MA 50$0.39
MA 200$0.44
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
Target Price$1.50
Upside/Downside302.14%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.65
Volatility62.18%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.